Tirzepatide studies: 457 papers with results
Page 5 of 10
- Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta analysis.
Safwan M · Annals of Saudi medicine · 2025
Systematic review · 9 results
- Who Wins the Battle Against Obesity? A Network Meta-Analysis Comparing Tirzepatide and Semaglutide.
Bernardi JC · Journal of diabetes · 2026
Systematic review · 6 results
- The gynecologic tumor risk related to GLP-1 receptor agonists and SGLT2 inhibitors use: a network meta-analysis of 91 randomized controlled trials.
Tseng PT · Journal of hematology & oncology · 2025
Systematic review · 3 results
- Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis.
Masson W · Reviews in endocrine & metabolic disorders · 2026
Systematic review · 8 results
- Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Kommu S · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
Systematic review · 11 results
- Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5-15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials.
Singh A · Diabetes & metabolic syndrome · 2025
Systematic review · 4 results
- Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.
Damen JAA · Annals of internal medicine · 2026
Systematic review · 6 results
- GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling.
Gupta AK · Science progress · 2026
Systematic review · 19 results
- Weight Loss as a Determinant of Histological Improvement in Metabolic Dysfunction-Associated Steatotic Liver Disease in People With Obesity. A Systematic Review and Network Meta-Analysis of Randomised Clinical Trials.
Monami M · Diabetes, obesity & metabolism · 2026
Systematic review · 2 results
- Quantitative Comparison of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Adults: A Systematic Review and Model-Based Meta-Analysis.
Zhang S · Diabetes technology & therapeutics · 2025
Systematic review · 13 results
- Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis.
Teng Y · BMC endocrine disorders · 2024
Systematic review · 10 results
- Dose-Response Relationship of Glucagon-like Peptide-1 Receptor Agonists on HbA1c and Body Weight in Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis.
Chen QQ · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
Systematic review · 5 results
- Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis.
Shokravi A · Cardiovascular diabetology · 2026
Systematic review · 7 results
- Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials.
Ciudin A · Advances in therapy · 2026
Systematic review · 24 results
- Beyond GLP-1: efficacy and safety of dual and triple incretin agonists in personalized type 2 diabetes care-a systematic review and network meta-analysis.
Yan K · Acta diabetologica · 2025
Systematic review · 5 results
- Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.
Nong K · BMJ (Clinical research ed.) · 2026
Systematic review · 29 results
- Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials.
Hamarsheh S · Endocrinology, diabetes & metabolism · 2026
Systematic review · 14 results
- GLP-1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta-Analysis of RCTs.
Vienghirun J · Diabetes, obesity & metabolism · 2026
Systematic review · 20 results
- Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.
Rico-Fontalvo J · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
Systematic review · 9 results
- Comparative effectiveness and safety of novel antidiabetic agents in the management of obstructive sleep apnea: a systematic review, meta-analysis, and network meta-analysis.
Yang YT · Respiratory medicine · 2026
Systematic review · 5 results
- GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies.
Giugliano D · Diabetes, obesity & metabolism · 2026
Systematic review · 9 results
- Exploring the rates of Gastrointestinal adverse effects among five GLP-1 receptor agonists: A systematic review and Meta-Analysis of randomized controlled trials.
Joy B · Endocrine · 2026
Systematic review · 16 results
- Role of Incretin Mimetics in Cardiovascular Outcomes and Other Classical Cardiovascular Risk Factors beyond Obesity and Diabetes Mellitus in Nondiabetic Adults with Obesity: a Meta-analysis of Randomized Controlled Trials.
Kamarullah W · American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
Systematic review · 5 results
- Is tirzepatide 15 mg the preferred treatment strategy for type 2 diabetes? A meta-analysis and trial-sequence-analysis.
Yang XY · European review for medical and pharmacological sciences · 2023
Systematic review · 18 results
- Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis.
Silverii GA · Diabetes, obesity & metabolism · 2026
Systematic review · 3 results
- Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta-Analysis.
Rakhsha SS · Diabetes, obesity & metabolism · 2026
Systematic review · 6 results
- Weight Loss With GLP-1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta-Analysis.
Lim M · Obesity (Silver Spring, Md.) · 2026
Systematic review · 9 results
- Relative Efficacy of Next-Generation Incretin Therapies for Cardio-Renal Protection in Type 2 Diabetes: Evidence From a Network Meta-Analysis.
Pham TP · Diabetes, obesity & metabolism · 2026
Systematic review · 5 results
- Dose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting.
Nauck MA · Diabetes, obesity & metabolism · 2026
Systematic review · 10 results
- Head-to-head comparison of tirzepatide and semaglutide for weight loss: A systematic review and meta-analysis.
Zufry H · Obesity research & clinical practice · 2026
Systematic review · 12 results
- Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and pairwise and network meta-analysis of randomized controlled trials.
Zhang Y · European journal of medical research · 2026
Systematic review · 10 results
- Role of Dual GIP and GLP-1 Receptor Agonist, Tirzepatide in the Management of Weight Loss; A Systematic Review.
Rangraze IR · Current drug safety · 2026
Systematic review · 5 results
- Effect of Tirzepatide on arrhythmic, major cardiovascular, and neurological outcomes in patients with type 2 diabetes: A systematic review and meta-analysis.
Wu R · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
Systematic review · 8 results
- Effects of Semaglutide and Tirzepatide on Recurrent Weight Gain After Bariatric Surgery: A Systematic Review and Meta-analysis.
Osorio Manyari AA · Obesity surgery · 2025
Systematic review · 2 results
- The efficacy and safety of dual GIP/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis.
Hoffmann K · Expert opinion on drug safety · 2026
Systematic review · 9 results
- Efficacy and safety of different once-weekly glucagon-like peptide-1 receptor agonists-A systematic review and Bayesian network meta-analysis.
Xu Y · Diabetes research and clinical practice · 2025
Systematic review · 6 results
- Medical treatments for obesity: what does the future have in store?
Bassatne A · The Journal of clinical endocrinology and metabolism · 2026
Systematic review · 2 results
- Weight Reduction Heterogenicity and Mediators of GLP-1RAs and Dual Agonists for Individuals With Obesity: A Meta-Analysis.
Lu D · Clinical obesity · 2026
Systematic review · 5 results
- Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis.
Qi H · PeerJ · 2026
Systematic review · 17 results
- Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review.
Puspitasari IM · Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
Systematic review · 10 results
- Weight Regain Trajectories After Discontinuation of Semaglutide or Tirzepatide: A Reconstructed Aggregate-Data Bayesian Longitudinal Meta-Analysis.
Kow CS · Endocrinology, diabetes & metabolism · 2026
Systematic review · 14 results
- Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.
Moiz A · Annals of internal medicine · 2026
Systematic review · 28 results
- Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials.
Hageen AW · Endocrinology, diabetes & metabolism · 2026
Systematic review · 11 results
- Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials.
Chen D · BMJ medicine · 2026
Systematic review · 7 results
- Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis.
Santos-Pereira M · Frontiers in endocrinology · 2026
Systematic review · 10 results
- Effect of tirzepatide and semaglutide on blood pressure: A systematic review and meta-analysis.
Chen QX · Endocrine · 2026
Systematic review · 5 results
- From pathobiology to prescribing in obesity-driven HFpEF: A systematic review and practical therapeutic framework.
Alhazmi AM · Current problems in cardiology · 2026
Systematic review · 6 results
- Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis.
Pałka W · Journal of endocrinological investigation · 2026
Systematic review · 22 results
- Nutritional intake changes during GLP-1 receptor agonist therapy: A systematic review and meta-analysis.
Quan AT · Diabetes & metabolic syndrome · 2026
Systematic review · 6 results
- Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus: a network meta-analysis based on clinical trials.
Wu X · Frontiers in pharmacology · 2026
Systematic review · 24 results